Eliem Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 11/14/2024 | 31.42 M | $159.92 M | 0.00% | 103.52% |
| JANUS HENDERSON GROUP PLC | 11/14/2024 | 3.61 M | $18.30 M | 10.83% | 11.88% |
| SAMSARA BIOCAPITAL, LLC | 11/14/2024 | 2.61 M | $13.28 M | -20.00% | 8.60% |
| BOXER CAPITAL, LLC | 11/14/2024 | 2.60 M | $13.25 M | 0.00% | 8.58% |
| DEEP TRACK CAPITAL, LP | 11/14/2024 | 2.17 M | $11.04 M | -44.45% | 7.15% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 1.87 M | $9.50 M | 100.00% | 6.15% |
| VANGUARD GROUP INC | 11/13/2024 | 1.52 M | $7.76 M | 367.20% | 5.02% |
| AFFINITY ASSET ADVISORS, LLC | 11/13/2024 | 1.50 M | $7.64 M | -10.22% | 4.94% |
| ALLY BRIDGE GROUP (NY) LLC | 11/14/2024 | 1.23 M | $6.26 M | 145.86% | 4.05% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 672,566 | $3.43 M | 100.00% | 2.22% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 651,297 | $3.32 M | 279.55% | 2.15% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 11/14/2024 | 612,387 | $3.12 M | -12.02% | 2.02% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2024 | 590,946 | $3.01 M | 100.00% | 1.95% |
| NAN FUNG GROUP HOLDINGS LTD | 11/13/2024 | 463,654 | $2.36 M | 100.00% | 1.53% |
| STATE STREET CORP | 11/14/2024 | 315,036 | $1.60 M | 433.90% | 1.04% |
| PARKMAN HEALTHCARE PARTNERS LLC | 11/14/2024 | 278,775 | $1.42 M | 100.00% | 0.92% |
| GREAT POINT PARTNERS LLC | 11/13/2024 | 248,168 | $1.26 B | 100.00% | 0.82% |
| MONASHEE INVESTMENT MANAGEMENT LLC | 11/12/2024 | 230,000 | $1.17 M | 100.00% | 0.76% |
| SPHERA FUNDS MANAGEMENT LTD. | 11/14/2024 | 181,970 | $926,227 | -15.43% | 0.60% |
| IKARIAN CAPITAL, LLC | 11/14/2024 | 175,100 | $891,258 | 75.10% | 0.58% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 11/14/2024 | 163,443 | $831,925 | 67.30% | 0.54% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 111,137 | $565,687 | 875.14% | 0.37% |
| TD ASSET MANAGEMENT INC | 11/01/2024 | 89,400 | $445,212 | 100.00% | 0.29% |
| MORGAN STANLEY | 11/14/2024 | 78,181 | $397,941 | 691.07% | 0.26% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 70,093 | $356,773 | 309.23% | 0.23% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 68,600 | $349,174 | 85.41% | 0.23% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 64,914 | $330,412 | 244.46% | 0.21% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 59,046 | $300,544 | 100.00% | 0.19% |
| SEGALL BRYANT & HAMILL, LLC | 11/08/2024 | 58,411 | $297,312 | 100.00% | 0.19% |
| ACUTA CAPITAL PARTNERS, LLC | 11/14/2024 | 54,000 | $274,860 | 100.00% | 0.18% |
| BOOTHBAY FUND MANAGEMENT, LLC | 11/14/2024 | 53,674 | $273,201 | 74.78% | 0.18% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 11/13/2024 | 49,524 | $252,077 | 100.00% | 0.16% |
| ADVANTAGE ALPHA CAPITAL PARTNERS LP | 11/13/2024 | 48,169 | $245,180 | 100.00% | 0.16% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 39,034 | $198,683 | 100.00% | 0.13% |
| BARCLAYS PLC | 11/19/2024 | 38,859 | $198,000 | 1,428.08% | 0.13% |
| SUPERSTRING CAPITAL MANAGEMENT LP | 11/14/2024 | 33,824 | $172,164 | 100.00% | 0.11% |
| RHUMBLINE ADVISERS | 11/12/2024 | 27,740 | $141,189 | 236.94% | 0.09% |
| WINTON GROUP LTD | 11/12/2024 | 27,551 | $140,235 | 100.00% | 0.09% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 23,514 | $119,686 | 100.00% | 0.08% |
| DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 18,280 | $93,045 | 45.54% | 0.06% |
| METLIFE INVESTMENT MANAGEMENT, LLC | 11/13/2024 | 17,769 | $90,444 | 100.00% | 0.06% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 17,369 | $88,408 | 87.83% | 0.06% |
| CHICAGO PARTNERS INVESTMENT GROUP LLC | 10/29/2024 | 16,966 | $80,589 | 100.00% | 0.06% |
| UBS GROUP AG | 11/14/2024 | 16,247 | $82,697 | 632.51% | 0.05% |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 11/14/2024 | 16,064 | $81,766 | 100.00% | 0.05% |
| COREBRIDGE FINANCIAL, INC. | 11/13/2024 | 15,733 | $80,081 | 301.56% | 0.05% |
| AMERICAN CENTURY COMPANIES INC | 11/12/2024 | 13,885 | $70,675 | 100.00% | 0.05% |
| WELLS FARGO & COMPANY/MN | 11/13/2024 | 13,248 | $67,432 | 320.71% | 0.04% |
| JPMORGAN CHASE & CO | 11/08/2024 | 12,776 | $65,030 | 311.60% | 0.04% |
| VALENCE8 US LP | 11/12/2024 | 12,045 | $61,309 | 100.00% | 0.04% |
Eliem Therapeutics, Inc.institutional Ownership - FAQ's
During the previous two years, 78 institutional investors and hedge funds held shares of Eliem Therapeutics, Inc.. The most heavily invested institutionals were:
RA CAPITAL MANAGEMENT, L.P.: 31.42 M
JANUS HENDERSON GROUP PLC: 3.61 M
Samsara BioCapital, LLC: 2.61 M
Boxer Capital, LLC: 2.6 M
Deep Track Capital, LP: 2.17 M
BlackRock Funding, Inc. /DE: 1.87 M
180.12% of Eliem Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 54.73 M shares in the last 24 months. This purchase volume represents approximately $279.69 M in transactions.